

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of vesicle fusion (GO:0031340) | 8.40570505 |
| 2 | L-glutamate transport (GO:0015813) | 8.03136601 |
| 3 | acidic amino acid transport (GO:0015800) | 7.74942226 |
| 4 | microtubule nucleation (GO:0007020) | 6.87920052 |
| 5 | peptidyl-arginine methylation (GO:0018216) | 5.82561176 |
| 6 | peptidyl-arginine N-methylation (GO:0035246) | 5.82561176 |
| 7 | centrosome localization (GO:0051642) | 5.77985097 |
| 8 | dermatan sulfate biosynthetic process (GO:0030208) | 5.55268839 |
| 9 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 5.54371492 |
| 10 | presynaptic membrane assembly (GO:0097105) | 5.53021733 |
| 11 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 5.49332184 |
| 12 | negative regulation of Ras GTPase activity (GO:0034261) | 5.41427579 |
| 13 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.35411629 |
| 14 | positive regulation of growth hormone secretion (GO:0060124) | 5.33553983 |
| 15 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 5.20441149 |
| 16 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.18842410 |
| 17 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 5.16851621 |
| 18 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 5.16851621 |
| 19 | establishment of protein localization to Golgi (GO:0072600) | 5.13510464 |
| 20 | somite rostral/caudal axis specification (GO:0032525) | 5.08903315 |
| 21 | axonal fasciculation (GO:0007413) | 5.04374973 |
| 22 | protein targeting to Golgi (GO:0000042) | 5.01505427 |
| 23 | dermatan sulfate metabolic process (GO:0030205) | 4.99082930 |
| 24 | G-protein coupled receptor internalization (GO:0002031) | 4.91394194 |
| 25 | detection of temperature stimulus (GO:0016048) | 4.90743106 |
| 26 | presynaptic membrane organization (GO:0097090) | 4.85331450 |
| 27 | regulation of protein kinase A signaling (GO:0010738) | 4.75220909 |
| 28 | peristalsis (GO:0030432) | 4.74588476 |
| 29 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 4.73262919 |
| 30 | regulation of vesicle fusion (GO:0031338) | 4.67861956 |
| 31 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 4.66467380 |
| 32 | histamine secretion (GO:0001821) | 4.65443910 |
| 33 | cellular response to ATP (GO:0071318) | 4.62073533 |
| 34 | regulation of clathrin-mediated endocytosis (GO:2000369) | 4.51634911 |
| 35 | behavioral defense response (GO:0002209) | 4.51431935 |
| 36 | behavioral fear response (GO:0001662) | 4.51431935 |
| 37 | regulation of penile erection (GO:0060405) | 4.50698299 |
| 38 | GTP biosynthetic process (GO:0006183) | 4.47570878 |
| 39 | prepulse inhibition (GO:0060134) | 4.38167512 |
| 40 | galactose catabolic process (GO:0019388) | 4.37380092 |
| 41 | neuronal action potential propagation (GO:0019227) | 4.29401004 |
| 42 | detection of calcium ion (GO:0005513) | 4.20005485 |
| 43 | suckling behavior (GO:0001967) | 4.17400694 |
| 44 | dicarboxylic acid transport (GO:0006835) | 4.10184110 |
| 45 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 4.08479985 |
| 46 | early endosome to late endosome transport (GO:0045022) | 4.08081720 |
| 47 | synaptic vesicle maturation (GO:0016188) | 4.04202571 |
| 48 | negative regulation of norepinephrine secretion (GO:0010700) | 3.94995015 |
| 49 | regulation of telomere maintenance (GO:0032204) | 3.94977256 |
| 50 | microtubule anchoring (GO:0034453) | 3.93397422 |
| 51 | synaptic transmission, dopaminergic (GO:0001963) | 3.93222163 |
| 52 | fear response (GO:0042596) | 3.90897191 |
| 53 | neuron recognition (GO:0008038) | 3.88654724 |
| 54 | peptidyl-threonine dephosphorylation (GO:0035970) | 3.88475841 |
| 55 | activation of adenylate cyclase activity (GO:0007190) | 3.84627252 |
| 56 | negative regulation of glial cell proliferation (GO:0060253) | 3.84221743 |
| 57 | cell migration in hindbrain (GO:0021535) | 3.83744507 |
| 58 | regulation of growth hormone secretion (GO:0060123) | 3.82410077 |
| 59 | UTP biosynthetic process (GO:0006228) | 3.81290074 |
| 60 | regulation of protein heterodimerization activity (GO:0043497) | 3.80683482 |
| 61 | chemosensory behavior (GO:0007635) | 3.76945149 |
| 62 | microtubule severing (GO:0051013) | 3.76618715 |
| 63 | protein localization to Golgi apparatus (GO:0034067) | 3.75307875 |
| 64 | synaptic vesicle exocytosis (GO:0016079) | 3.73928456 |
| 65 | neuronal ion channel clustering (GO:0045161) | 3.72584821 |
| 66 | negative regulation of acute inflammatory response (GO:0002674) | 3.71791079 |
| 67 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.70708335 |
| 68 | axon regeneration (GO:0031103) | 3.69743799 |
| 69 | response to pheromone (GO:0019236) | 3.68871133 |
| 70 | synapse assembly (GO:0007416) | 3.66932643 |
| 71 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.64430441 |
| 72 | striatum development (GO:0021756) | 3.63996531 |
| 73 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.62499847 |
| 74 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.61381889 |
| 75 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.60936785 |
| 76 | glutamate receptor signaling pathway (GO:0007215) | 3.60429790 |
| 77 | activation of protein kinase A activity (GO:0034199) | 3.60060940 |
| 78 | histamine transport (GO:0051608) | 3.59979688 |
| 79 | protein localization to synapse (GO:0035418) | 3.59140627 |
| 80 | peptidyl-arginine modification (GO:0018195) | 3.57140018 |
| 81 | vocalization behavior (GO:0071625) | 3.56127560 |
| 82 | startle response (GO:0001964) | 3.54976636 |
| 83 | auditory behavior (GO:0031223) | 3.54392238 |
| 84 | peptidyl-arginine omega-N-methylation (GO:0035247) | 3.53144656 |
| 85 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.52759807 |
| 86 | positive regulation of microtubule polymerization or depolymerization (GO:0031112) | 3.51670474 |
| 87 | response to auditory stimulus (GO:0010996) | 3.50064255 |
| 88 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.49910475 |
| 89 | positive regulation of Rap GTPase activity (GO:0032854) | 3.49088280 |
| 90 | positive regulation of adenylate cyclase activity (GO:0045762) | 3.47859201 |
| 91 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.47853897 |
| 92 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.46960304 |
| 93 | glutamate secretion (GO:0014047) | 3.46870058 |
| 94 | regulation of synapse structural plasticity (GO:0051823) | 3.45546040 |
| 95 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.45340833 |
| 96 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.45340833 |
| 97 | regulation of postsynaptic membrane potential (GO:0060078) | 3.44720668 |
| 98 | regulation of acute inflammatory response to antigenic stimulus (GO:0002864) | 3.44528086 |
| 99 | neuromuscular process controlling posture (GO:0050884) | 3.43129212 |
| 100 | C4-dicarboxylate transport (GO:0015740) | 3.41893432 |
| 101 | UTP metabolic process (GO:0046051) | 3.41139996 |
| 102 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.41117753 |
| 103 | somite development (GO:0061053) | 3.40770200 |
| 104 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.40565030 |
| 105 | L-amino acid transport (GO:0015807) | 3.40496319 |
| 106 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G- | 3.39515200 |
| 107 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.38011484 |
| 108 | regulation of Rap GTPase activity (GO:0032317) | 3.33312243 |
| 109 | neuron-neuron synaptic transmission (GO:0007270) | 3.32688080 |
| 110 | dopamine receptor signaling pathway (GO:0007212) | 3.31595270 |
| 111 | neurotransmitter secretion (GO:0007269) | 3.30045420 |
| 112 | transmission of nerve impulse (GO:0019226) | 3.28035243 |
| 113 | retinal ganglion cell axon guidance (GO:0031290) | 3.27626814 |
| 114 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 3.27151846 |
| 115 | resolution of meiotic recombination intermediates (GO:0000712) | 3.25525817 |
| 116 | locomotory exploration behavior (GO:0035641) | 3.24849338 |
| 117 | galactose metabolic process (GO:0006012) | 3.22836548 |
| 118 | * positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.22722021 |
| 119 | sex differentiation (GO:0007548) | 3.22329826 |
| 120 | neurotransmitter transport (GO:0006836) | 3.21439215 |
| 121 | negative regulation of catecholamine secretion (GO:0033604) | 3.21432578 |
| 122 | behavioral response to cocaine (GO:0048148) | 3.20065787 |
| 123 | regulation of glutamate secretion (GO:0014048) | 3.16717403 |
| 124 | neuronal action potential (GO:0019228) | 3.16532733 |
| 125 | neuromuscular process controlling balance (GO:0050885) | 3.16249123 |
| 126 | neuron cell-cell adhesion (GO:0007158) | 3.16203765 |
| 127 | * regulation of synaptic transmission, GABAergic (GO:0032228) | 3.16088534 |
| 128 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.15406627 |
| 129 | regulation of collateral sprouting (GO:0048670) | 3.13987489 |
| 130 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.13127659 |
| 131 | response to BMP (GO:0071772) | 3.11466498 |
| 132 | cellular response to BMP stimulus (GO:0071773) | 3.11466498 |
| 133 | positive regulation of gastrulation (GO:2000543) | 3.09995313 |
| 134 | S-adenosylmethionine metabolic process (GO:0046500) | 3.08579466 |
| 135 | * sensory perception of pain (GO:0019233) | 3.07642165 |
| 136 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.07526904 |
| 137 | protein neddylation (GO:0045116) | 3.06576482 |
| 138 | negative regulation of dendrite development (GO:2000171) | 3.04305948 |
| 139 | mating behavior (GO:0007617) | 3.04290732 |
| 140 | synaptic transmission, glutamatergic (GO:0035249) | 3.03855551 |
| 141 | exploration behavior (GO:0035640) | 3.02758367 |
| 142 | DNA double-strand break processing (GO:0000729) | 3.02044506 |
| 143 | regulation of adenylate cyclase activity (GO:0045761) | 3.00957443 |
| 144 | negative regulation of GTP catabolic process (GO:0033125) | 3.00821755 |
| 145 | negative regulation of GTPase activity (GO:0034260) | 3.00821755 |
| 146 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.00383114 |
| 147 | response to histamine (GO:0034776) | 2.99570783 |
| 148 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.99480435 |
| 149 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.98654537 |
| 150 | response to amphetamine (GO:0001975) | 2.97999837 |
| 151 | signal transduction involved in regulation of gene expression (GO:0023019) | 2.95529288 |
| 152 | adenosine receptor signaling pathway (GO:0001973) | 2.95514865 |
| 153 | axon development (GO:0061564) | 2.94630395 |
| 154 | negative regulation of microtubule polymerization (GO:0031115) | 2.93842555 |
| 155 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.93743071 |
| 156 | negative regulation of potassium ion transport (GO:0043267) | 2.93347726 |
| 157 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.93269972 |
| 158 | gamma-aminobutyric acid transport (GO:0015812) | 2.92911087 |
| 159 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.92581070 |
| 160 | regulation of synaptic vesicle transport (GO:1902803) | 2.92420527 |
| 161 | nucleobase catabolic process (GO:0046113) | 2.92107548 |
| 162 | cAMP-mediated signaling (GO:0019933) | 2.91439076 |
| 163 | * long-term memory (GO:0007616) | 2.91322353 |
| 164 | positive regulation of cyclase activity (GO:0031281) | 2.90284640 |
| 165 | embryonic foregut morphogenesis (GO:0048617) | 2.90160611 |
| 166 | regulation of female receptivity (GO:0045924) | 2.89469651 |
| 167 | layer formation in cerebral cortex (GO:0021819) | 2.88673346 |
| 168 | axon extension (GO:0048675) | 2.87107925 |
| 169 | RNA destabilization (GO:0050779) | 2.86462415 |
| 170 | axonogenesis (GO:0007409) | 2.86383133 |
| 171 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.84908953 |
| 172 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.84339259 |
| 173 | phasic smooth muscle contraction (GO:0014821) | 2.84284948 |
| 174 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway (GO:0007193) | 2.84008262 |
| 175 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.83880450 |
| 176 | organelle transport along microtubule (GO:0072384) | 2.83564105 |
| 177 | * neuropeptide signaling pathway (GO:0007218) | 2.82665821 |
| 178 | nucleoside diphosphate phosphorylation (GO:0006165) | 2.82289174 |
| 179 | positive regulation of erythrocyte differentiation (GO:0045648) | 2.81997599 |
| 180 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157) | 2.81832197 |
| 181 | ribonucleoprotein complex disassembly (GO:0032988) | 2.80575123 |
| 182 | transepithelial transport (GO:0070633) | 2.79040076 |
| 183 | postreplication repair (GO:0006301) | 2.78147750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.28315125 |
| 2 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.38740663 |
| 3 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 3.38573473 |
| 4 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 3.24958571 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.20080878 |
| 6 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.06772435 |
| 7 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.06692348 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.84269705 |
| 9 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.83692114 |
| 10 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.79712750 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.78379946 |
| 12 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.78115047 |
| 13 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.76684064 |
| 14 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.72989541 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.71748344 |
| 16 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.70737577 |
| 17 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.69437340 |
| 18 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.67359798 |
| 19 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.66349525 |
| 20 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.65167436 |
| 21 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.62736509 |
| 22 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.62736509 |
| 23 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.61578686 |
| 24 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.56033081 |
| 25 | VDR_22108803_ChIP-Seq_LS180_Human | 2.55003659 |
| 26 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.54074548 |
| 27 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.51924916 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.51877009 |
| 29 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.47399940 |
| 30 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.41364546 |
| 31 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.33478391 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.29886628 |
| 33 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.29300827 |
| 34 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.18630152 |
| 35 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.14222507 |
| 36 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.13498775 |
| 37 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.09410186 |
| 38 | EWS_26573619_Chip-Seq_HEK293_Human | 2.03894836 |
| 39 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.98550124 |
| 40 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.92920504 |
| 41 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.91671452 |
| 42 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.87904332 |
| 43 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.83205350 |
| 44 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.74159675 |
| 45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.71159847 |
| 46 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.69079382 |
| 47 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.62592406 |
| 48 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.61762959 |
| 49 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.59407838 |
| 50 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.59174729 |
| 51 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.55565538 |
| 52 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.54486285 |
| 53 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.51884016 |
| 54 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.49284843 |
| 55 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.47527456 |
| 56 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.47217779 |
| 57 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.46726866 |
| 58 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.45190602 |
| 59 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44660418 |
| 60 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.44513926 |
| 61 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.44062956 |
| 62 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.41721346 |
| 63 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.41658208 |
| 64 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.41409370 |
| 65 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.38901616 |
| 66 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.38897664 |
| 67 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.37330068 |
| 68 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.37228206 |
| 69 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.37195285 |
| 70 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.37118219 |
| 71 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.35609999 |
| 72 | SOX9_26525672_Chip-Seq_Limbbuds_Mouse | 1.32769543 |
| 73 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.30608594 |
| 74 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.29642291 |
| 75 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.28499284 |
| 76 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.27222209 |
| 77 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.26648289 |
| 78 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.26387368 |
| 79 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.25239451 |
| 80 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.25239451 |
| 81 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.23666015 |
| 82 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.23534031 |
| 83 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.22462001 |
| 84 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21501823 |
| 85 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.21068506 |
| 86 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20937684 |
| 87 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.20646851 |
| 88 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.19478418 |
| 89 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.18416677 |
| 90 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.17572857 |
| 91 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.17542883 |
| 92 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.16998421 |
| 93 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.16920518 |
| 94 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.15138724 |
| 95 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.14304647 |
| 96 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.13636603 |
| 97 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13614780 |
| 98 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.13523366 |
| 99 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.13352440 |
| 100 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.11903078 |
| 101 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.10480436 |
| 102 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.09176411 |
| 103 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.08541334 |
| 104 | AR_25329375_ChIP-Seq_VCAP_Human | 1.08365252 |
| 105 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.06485534 |
| 106 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.06149759 |
| 107 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.05930836 |
| 108 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.04626788 |
| 109 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.04203080 |
| 110 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.03554315 |
| 111 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03467623 |
| 112 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.01714007 |
| 113 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.01714007 |
| 114 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.01475070 |
| 115 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.99135243 |
| 116 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.99125506 |
| 117 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.98971040 |
| 118 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98904349 |
| 119 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97176571 |
| 120 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.96073554 |
| 121 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 0.95783175 |
| 122 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.94949835 |
| 123 | KDM2B_26808549_Chip-Seq_REH_Human | 0.94539746 |
| 124 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.94250597 |
| 125 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.92286232 |
| 126 | KDM2B_26808549_Chip-Seq_K562_Human | 0.91464939 |
| 127 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.91072585 |
| 128 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.89697251 |
| 129 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.89215686 |
| 130 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.87952466 |
| 131 | JUN_21703547_ChIP-Seq_K562_Human | 0.87942178 |
| 132 | * ER_23166858_ChIP-Seq_MCF-7_Human | 0.87660807 |
| 133 | AR_19668381_ChIP-Seq_PC3_Human | 0.87363225 |
| 134 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.85861210 |
| 135 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.85158111 |
| 136 | TCF4_23295773_ChIP-Seq_U87_Human | 0.84951824 |
| 137 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.84633542 |
| 138 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.82553586 |
| 139 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.80764250 |
| 140 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.77946374 |
| 141 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.75021937 |
| 142 | FUS_26573619_Chip-Seq_HEK293_Human | 0.73380115 |
| 143 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.73129403 |
| 144 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.71692992 |
| 145 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.71160235 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002735_abnormal_chemical_nociception | 5.14352914 |
| 2 | MP0001968_abnormal_touch/_nociception | 4.44662468 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 4.37213391 |
| 4 | MP0004270_analgesia | 4.19601630 |
| 5 | MP0003880_abnormal_central_pattern | 3.97747747 |
| 6 | MP0002822_catalepsy | 3.76541912 |
| 7 | MP0006276_abnormal_autonomic_nervous | 3.72049593 |
| 8 | MP0002736_abnormal_nociception_after | 3.49683406 |
| 9 | MP0009745_abnormal_behavioral_response | 3.34313493 |
| 10 | MP0001986_abnormal_taste_sensitivity | 3.33759537 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 3.23846908 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 3.14035937 |
| 13 | * MP0010386_abnormal_urinary_bladder | 3.09124367 |
| 14 | MP0001440_abnormal_grooming_behavior | 2.98019245 |
| 15 | MP0003787_abnormal_imprinting | 2.94801747 |
| 16 | MP0002733_abnormal_thermal_nociception | 2.91071246 |
| 17 | MP0002063_abnormal_learning/memory/cond | 2.88444625 |
| 18 | MP0003123_paternal_imprinting | 2.77586604 |
| 19 | * MP0001970_abnormal_pain_threshold | 2.74038666 |
| 20 | * MP0002572_abnormal_emotion/affect_behav | 2.59735813 |
| 21 | MP0009046_muscle_twitch | 2.58368740 |
| 22 | MP0002064_seizures | 2.55092761 |
| 23 | MP0002272_abnormal_nervous_system | 2.54074298 |
| 24 | MP0001529_abnormal_vocalization | 2.26578744 |
| 25 | MP0003121_genomic_imprinting | 2.18987363 |
| 26 | MP0001486_abnormal_startle_reflex | 2.02946635 |
| 27 | MP0002184_abnormal_innervation | 1.95074483 |
| 28 | MP0005386_behavior/neurological_phenoty | 1.93217949 |
| 29 | MP0004924_abnormal_behavior | 1.93217949 |
| 30 | MP0004133_heterotaxia | 1.88526202 |
| 31 | MP0004858_abnormal_nervous_system | 1.87773822 |
| 32 | MP0004145_abnormal_muscle_electrophysio | 1.87553098 |
| 33 | MP0002067_abnormal_sensory_capabilities | 1.85135809 |
| 34 | MP0005187_abnormal_penis_morphology | 1.83088749 |
| 35 | MP0001501_abnormal_sleep_pattern | 1.79257933 |
| 36 | MP0005423_abnormal_somatic_nervous | 1.77571362 |
| 37 | MP0001188_hyperpigmentation | 1.72897987 |
| 38 | MP0000538_abnormal_urinary_bladder | 1.70612190 |
| 39 | MP0001905_abnormal_dopamine_level | 1.68322668 |
| 40 | MP0002909_abnormal_adrenal_gland | 1.63816464 |
| 41 | MP0000569_abnormal_digit_pigmentation | 1.55729471 |
| 42 | MP0003221_abnormal_cardiomyocyte_apopto | 1.55077287 |
| 43 | MP0002557_abnormal_social/conspecific_i | 1.50392900 |
| 44 | MP0005410_abnormal_fertilization | 1.46385768 |
| 45 | MP0004142_abnormal_muscle_tone | 1.43934953 |
| 46 | MP0000751_myopathy | 1.37598394 |
| 47 | MP0003283_abnormal_digestive_organ | 1.37080367 |
| 48 | MP0003195_calcinosis | 1.36659534 |
| 49 | MP0003329_amyloid_beta_deposits | 1.35568746 |
| 50 | MP0008872_abnormal_physiological_respon | 1.35493810 |
| 51 | MP0008877_abnormal_DNA_methylation | 1.34373517 |
| 52 | MP0004811_abnormal_neuron_physiology | 1.32110004 |
| 53 | MP0008569_lethality_at_weaning | 1.30175071 |
| 54 | MP0001727_abnormal_embryo_implantation | 1.28898121 |
| 55 | MP0003890_abnormal_embryonic-extraembry | 1.28141820 |
| 56 | MP0002882_abnormal_neuron_morphology | 1.24992136 |
| 57 | MP0002066_abnormal_motor_capabilities/c | 1.24462001 |
| 58 | MP0003879_abnormal_hair_cell | 1.24135345 |
| 59 | MP0005535_abnormal_body_temperature | 1.20326423 |
| 60 | MP0001984_abnormal_olfaction | 1.19942478 |
| 61 | MP0000778_abnormal_nervous_system | 1.18098000 |
| 62 | MP0003122_maternal_imprinting | 1.17625110 |
| 63 | MP0008874_decreased_physiological_sensi | 1.16604928 |
| 64 | MP0000631_abnormal_neuroendocrine_gland | 1.12228974 |
| 65 | MP0001919_abnormal_reproductive_system | 1.10712093 |
| 66 | MP0000955_abnormal_spinal_cord | 1.09316739 |
| 67 | MP0002234_abnormal_pharynx_morphology | 1.08251464 |
| 68 | MP0001502_abnormal_circadian_rhythm | 1.06225943 |
| 69 | MP0005503_abnormal_tendon_morphology | 1.03732744 |
| 70 | MP0004147_increased_porphyrin_level | 1.01994822 |
| 71 | MP0006072_abnormal_retinal_apoptosis | 1.01480327 |
| 72 | MP0003119_abnormal_digestive_system | 0.99651059 |
| 73 | MP0008775_abnormal_heart_ventricle | 0.98645978 |
| 74 | MP0000920_abnormal_myelination | 0.95580197 |
| 75 | MP0004085_abnormal_heartbeat | 0.93571943 |
| 76 | MP0003633_abnormal_nervous_system | 0.93262897 |
| 77 | MP0002837_dystrophic_cardiac_calcinosis | 0.93250689 |
| 78 | MP0005367_renal/urinary_system_phenotyp | 0.92100239 |
| 79 | MP0000516_abnormal_urinary_system | 0.92100239 |
| 80 | MP0004484_altered_response_of | 0.91034029 |
| 81 | MP0004742_abnormal_vestibular_system | 0.90926212 |
| 82 | MP0002160_abnormal_reproductive_system | 0.90407174 |
| 83 | MP0002751_abnormal_autonomic_nervous | 0.88314175 |
| 84 | MP0000647_abnormal_sebaceous_gland | 0.87718252 |
| 85 | MP0002229_neurodegeneration | 0.87399552 |
| 86 | MP0004885_abnormal_endolymph | 0.87182365 |
| 87 | MP0003183_abnormal_peptide_metabolism | 0.86174298 |
| 88 | MP0009780_abnormal_chondrocyte_physiolo | 0.84278056 |
| 89 | MP0003315_abnormal_perineum_morphology | 0.82803644 |
| 90 | MP0000026_abnormal_inner_ear | 0.81692098 |
| 91 | MP0002752_abnormal_somatic_nervous | 0.81440870 |
| 92 | MP0005248_abnormal_Harderian_gland | 0.78195705 |
| 93 | MP0001963_abnormal_hearing_physiology | 0.77251942 |
| 94 | MP0005670_abnormal_white_adipose | 0.76877399 |
| 95 | MP0003385_abnormal_body_wall | 0.76802765 |
| 96 | MP0002069_abnormal_eating/drinking_beha | 0.76569227 |
| 97 | MP0005551_abnormal_eye_electrophysiolog | 0.75415643 |
| 98 | MP0003634_abnormal_glial_cell | 0.74735863 |
| 99 | MP0003137_abnormal_impulse_conducting | 0.74325877 |
| 100 | MP0001542_abnormal_bone_strength | 0.74243991 |
| 101 | MP0003631_nervous_system_phenotype | 0.72842512 |
| 102 | MP0004036_abnormal_muscle_relaxation | 0.71122225 |
| 103 | MP0000427_abnormal_hair_cycle | 0.68477752 |
| 104 | MP0000604_amyloidosis | 0.66745418 |
| 105 | MP0000465_gastrointestinal_hemorrhage | 0.66550017 |
| 106 | MP0003690_abnormal_glial_cell | 0.66346046 |
| 107 | MP0005646_abnormal_pituitary_gland | 0.63952929 |
| 108 | MP0001485_abnormal_pinna_reflex | 0.61646841 |
| 109 | MP0002152_abnormal_brain_morphology | 0.60252081 |
| 110 | MP0000015_abnormal_ear_pigmentation | 0.60155311 |
| 111 | MP0005389_reproductive_system_phenotype | 0.58097496 |
| 112 | MP0000747_muscle_weakness | 0.57013018 |
| 113 | MP0003567_abnormal_fetal_cardiomyocyte | 0.56950885 |
| 114 | MP0001299_abnormal_eye_distance/ | 0.56571941 |
| 115 | MP0000230_abnormal_systemic_arterial | 0.56502928 |
| 116 | MP0003252_abnormal_bile_duct | 0.55509626 |
| 117 | MP0005645_abnormal_hypothalamus_physiol | 0.54510796 |
| 118 | MP0010307_abnormal_tumor_latency | 0.53620935 |
| 119 | MP0002177_abnormal_outer_ear | 0.53402783 |
| 120 | MP0000639_abnormal_adrenal_gland | 0.53238753 |
| 121 | MP0000013_abnormal_adipose_tissue | 0.53215419 |
| 122 | MP0006036_abnormal_mitochondrial_physio | 0.52439528 |
| 123 | MP0005195_abnormal_posterior_eye | 0.51994942 |
| 124 | MP0005083_abnormal_biliary_tract | 0.50803378 |
| 125 | MP0005448_abnormal_energy_balance | 0.49456007 |
| 126 | MP0003941_abnormal_skin_development | 0.48245238 |
| 127 | MP0003075_altered_response_to | 0.47899987 |
| 128 | MP0000579_abnormal_nail_morphology | 0.47404249 |
| 129 | MP0002876_abnormal_thyroid_physiology | 0.46753937 |
| 130 | MP0002090_abnormal_vision | 0.46241705 |
| 131 | MP0001177_atelectasis | 0.46015425 |
| 132 | MP0000749_muscle_degeneration | 0.45238138 |
| 133 | MP0001664_abnormal_digestion | 0.45204983 |
| 134 | MP0001765_abnormal_ion_homeostasis | 0.45052526 |
| 135 | MP0004883_abnormal_blood_vessel | 0.44339959 |
| 136 | MP0001943_abnormal_respiration | 0.44011797 |
| 137 | MP0005409_darkened_coat_color | 0.43889835 |
| 138 | MP0006035_abnormal_mitochondrial_morpho | 0.43338375 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 9.01075619 |
| 2 | Hip dysplasia (HP:0001385) | 7.50558226 |
| 3 | Thoracolumbar scoliosis (HP:0002944) | 7.45359454 |
| 4 | Focal motor seizures (HP:0011153) | 6.15170148 |
| 5 | Calf muscle hypertrophy (HP:0008981) | 5.04369534 |
| 6 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.87027269 |
| 7 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.87027269 |
| 8 | Difficulty running (HP:0009046) | 4.83934593 |
| 9 | Increased density of long bones (HP:0006392) | 4.81436360 |
| 10 | Shoulder girdle muscle weakness (HP:0003547) | 4.45960500 |
| 11 | Focal seizures (HP:0007359) | 4.39458722 |
| 12 | Pelvic girdle muscle weakness (HP:0003749) | 4.34748019 |
| 13 | Abnormality of the musculature of the pelvis (HP:0001469) | 3.90732559 |
| 14 | Abnormality of the hip-girdle musculature (HP:0001445) | 3.90732559 |
| 15 | Inappropriate behavior (HP:0000719) | 3.83335260 |
| 16 | Atonic seizures (HP:0010819) | 3.81095686 |
| 17 | Action tremor (HP:0002345) | 3.66709766 |
| 18 | Epileptic encephalopathy (HP:0200134) | 3.64710502 |
| 19 | Abnormality of pain sensation (HP:0010832) | 3.62648198 |
| 20 | Impaired pain sensation (HP:0007328) | 3.62648198 |
| 21 | Anxiety (HP:0000739) | 3.59743866 |
| 22 | Pheochromocytoma (HP:0002666) | 3.54372974 |
| 23 | Myotonia (HP:0002486) | 3.51301310 |
| 24 | Progressive cerebellar ataxia (HP:0002073) | 3.48664497 |
| 25 | Annular pancreas (HP:0001734) | 3.47582458 |
| 26 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 3.47110913 |
| 27 | Visual hallucinations (HP:0002367) | 3.46142965 |
| 28 | Febrile seizures (HP:0002373) | 3.36281739 |
| 29 | Absence seizures (HP:0002121) | 3.35765577 |
| 30 | Sensory axonal neuropathy (HP:0003390) | 3.32171116 |
| 31 | Genetic anticipation (HP:0003743) | 3.31720876 |
| 32 | Abnormal eating behavior (HP:0100738) | 3.31298102 |
| 33 | Fibular aplasia (HP:0002990) | 3.23747827 |
| 34 | Neuroendocrine neoplasm (HP:0100634) | 3.22666756 |
| 35 | Megalencephaly (HP:0001355) | 3.21790237 |
| 36 | Short tibia (HP:0005736) | 3.17307942 |
| 37 | Neoplasm of the peripheral nervous system (HP:0100007) | 3.15359046 |
| 38 | Obstructive sleep apnea (HP:0002870) | 3.15194394 |
| 39 | Protruding tongue (HP:0010808) | 3.14997958 |
| 40 | Generalized tonic-clonic seizures (HP:0002069) | 3.08453902 |
| 41 | Abnormal hair whorl (HP:0010721) | 3.05835054 |
| 42 | Disinhibition (HP:0000734) | 3.05568428 |
| 43 | Abnormality of the ischium (HP:0003174) | 3.00941080 |
| 44 | Sleep apnea (HP:0010535) | 2.97719915 |
| 45 | Depression (HP:0000716) | 2.96055950 |
| 46 | Dialeptic seizures (HP:0011146) | 2.95018754 |
| 47 | Rib fusion (HP:0000902) | 2.90020135 |
| 48 | Supranuclear gaze palsy (HP:0000605) | 2.88752556 |
| 49 | Abnormality of the 2nd finger (HP:0004100) | 2.88065445 |
| 50 | Severe short stature (HP:0003510) | 2.86793755 |
| 51 | Decreased muscle mass (HP:0003199) | 2.86782806 |
| 52 | Resting tremor (HP:0002322) | 2.85281801 |
| 53 | Renal cortical cysts (HP:0000803) | 2.84017640 |
| 54 | Hypoplastic ischia (HP:0003175) | 2.82153028 |
| 55 | Scanning speech (HP:0002168) | 2.80658257 |
| 56 | Difficulty climbing stairs (HP:0003551) | 2.77045069 |
| 57 | Abnormal gallbladder physiology (HP:0012438) | 2.76993114 |
| 58 | Cholecystitis (HP:0001082) | 2.76993114 |
| 59 | Hypoventilation (HP:0002791) | 2.75251483 |
| 60 | Truncal ataxia (HP:0002078) | 2.74426667 |
| 61 | Unilateral renal agenesis (HP:0000122) | 2.73169565 |
| 62 | Poor suck (HP:0002033) | 2.70470921 |
| 63 | Sudden death (HP:0001699) | 2.69316042 |
| 64 | Hyperventilation (HP:0002883) | 2.69156750 |
| 65 | Torticollis (HP:0000473) | 2.68196526 |
| 66 | Ankle clonus (HP:0011448) | 2.67127211 |
| 67 | Macroorchidism (HP:0000053) | 2.67124306 |
| 68 | Failure to thrive in infancy (HP:0001531) | 2.64543663 |
| 69 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.60251225 |
| 70 | Down-sloping shoulders (HP:0200021) | 2.60081493 |
| 71 | Dysmetria (HP:0001310) | 2.58977636 |
| 72 | Fair hair (HP:0002286) | 2.56236324 |
| 73 | Craniofacial dystonia (HP:0012179) | 2.53697352 |
| 74 | Testicular atrophy (HP:0000029) | 2.49484466 |
| 75 | Focal dystonia (HP:0004373) | 2.49227291 |
| 76 | Shawl scrotum (HP:0000049) | 2.46498630 |
| 77 | Drooling (HP:0002307) | 2.42602400 |
| 78 | Progressive inability to walk (HP:0002505) | 2.40310940 |
| 79 | Long toe (HP:0010511) | 2.38698701 |
| 80 | Nuclear cataract (HP:0100018) | 2.36963771 |
| 81 | Intellectual disability, severe (HP:0010864) | 2.36767757 |
| 82 | Delusions (HP:0000746) | 2.36549903 |
| 83 | Prominent nose (HP:0000448) | 2.35788049 |
| 84 | Hypercortisolism (HP:0001578) | 2.35373022 |
| 85 | Mutism (HP:0002300) | 2.27480073 |
| 86 | Acute necrotizing encephalopathy (HP:0006965) | 2.27311181 |
| 87 | Dysdiadochokinesis (HP:0002075) | 2.27143113 |
| 88 | Broad-based gait (HP:0002136) | 2.24391946 |
| 89 | Excessive salivation (HP:0003781) | 2.24365676 |
| 90 | Exotropia (HP:0000577) | 2.23010847 |
| 91 | Urinary urgency (HP:0000012) | 2.21565775 |
| 92 | Psychosis (HP:0000709) | 2.21209317 |
| 93 | Hypokinesia (HP:0002375) | 2.19507903 |
| 94 | Gait imbalance (HP:0002141) | 2.19403178 |
| 95 | Neurofibrillary tangles (HP:0002185) | 2.18731536 |
| 96 | Polyphagia (HP:0002591) | 2.17764030 |
| 97 | Proximal tubulopathy (HP:0000114) | 2.14029386 |
| 98 | Abnormality of the frontal sinuses (HP:0002687) | 2.13743739 |
| 99 | Papillary thyroid carcinoma (HP:0002895) | 2.13249711 |
| 100 | Amblyopia (HP:0000646) | 2.12248564 |
| 101 | Absent eyebrow (HP:0002223) | 2.11011328 |
| 102 | Microtia (HP:0008551) | 2.09962050 |
| 103 | Limb dystonia (HP:0002451) | 2.09330053 |
| 104 | Oligomenorrhea (HP:0000876) | 2.09192711 |
| 105 | Insidious onset (HP:0003587) | 2.08894099 |
| 106 | Termporal pattern (HP:0011008) | 2.08894099 |
| 107 | Bronchomalacia (HP:0002780) | 2.08687225 |
| 108 | Curly hair (HP:0002212) | 2.08660698 |
| 109 | Increased hepatocellular lipid droplets (HP:0006565) | 2.07047746 |
| 110 | Barrel-shaped chest (HP:0001552) | 2.06362048 |
| 111 | Spastic gait (HP:0002064) | 2.06175522 |
| 112 | Tetraplegia (HP:0002445) | 2.06096707 |
| 113 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.06077080 |
| 114 | Short phalanx of the thumb (HP:0009660) | 2.05952804 |
| 115 | Abnormality of the corticospinal tract (HP:0002492) | 2.05800981 |
| 116 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.03569832 |
| 117 | Foot dorsiflexor weakness (HP:0009027) | 2.03530684 |
| 118 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.03493091 |
| 119 | Gaze-evoked nystagmus (HP:0000640) | 2.03001818 |
| 120 | Lipid accumulation in hepatocytes (HP:0006561) | 2.02510153 |
| 121 | Bradykinesia (HP:0002067) | 2.01717962 |
| 122 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.01629125 |
| 123 | Testicular neoplasm (HP:0010788) | 2.01050678 |
| 124 | Hypotelorism (HP:0000601) | 2.00513887 |
| 125 | Cerebral hemorrhage (HP:0001342) | 1.99339550 |
| 126 | Amyotrophic lateral sclerosis (HP:0007354) | 1.97223404 |
| 127 | Severe global developmental delay (HP:0011344) | 1.96569643 |
| 128 | Progressive macrocephaly (HP:0004481) | 1.96369278 |
| 129 | Generalized hypotonia (HP:0001290) | 1.95678777 |
| 130 | Congenital primary aphakia (HP:0007707) | 1.92208701 |
| 131 | Restlessness (HP:0000711) | 1.92160277 |
| 132 | Hypophosphatemic rickets (HP:0004912) | 1.91442221 |
| 133 | Rapidly progressive (HP:0003678) | 1.91023338 |
| 134 | Neuronal loss in central nervous system (HP:0002529) | 1.91016571 |
| 135 | Apathy (HP:0000741) | 1.90909936 |
| 136 | Lower limb muscle weakness (HP:0007340) | 1.90814872 |
| 137 | Limb-girdle muscle weakness (HP:0003325) | 1.90542951 |
| 138 | Abnormality of the calf musculature (HP:0001430) | 1.90525758 |
| 139 | Broad distal phalanx of finger (HP:0009836) | 1.89238487 |
| 140 | Papilledema (HP:0001085) | 1.89099411 |
| 141 | Spinal canal stenosis (HP:0003416) | 1.88902894 |
| 142 | Poor eye contact (HP:0000817) | 1.86239574 |
| 143 | Type II lissencephaly (HP:0007260) | 1.86177992 |
| 144 | Macroglossia (HP:0000158) | 1.85796330 |
| 145 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.85608308 |
| 146 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.85353404 |
| 147 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 1.85210843 |
| 148 | Retinal dysplasia (HP:0007973) | 1.84362115 |
| 149 | Agitation (HP:0000713) | 1.82954458 |
| 150 | Achilles tendon contracture (HP:0001771) | 1.82445204 |
| 151 | Neuroblastoma (HP:0003006) | 1.82427855 |
| 152 | Primitive neuroectodermal tumor (HP:0030065) | 1.82427855 |
| 153 | Neuroblastic tumors (HP:0004376) | 1.82427855 |
| 154 | Peripheral primitive neuroectodermal neoplasm (HP:0030067) | 1.82427855 |
| 155 | Neoplasm of the heart (HP:0100544) | 1.82374064 |
| 156 | Stereotypic behavior (HP:0000733) | 1.81764002 |
| 157 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.81515248 |
| 158 | Generalized hypopigmentation of hair (HP:0011358) | 1.80627222 |
| 159 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.79685656 |
| 160 | Primary amenorrhea (HP:0000786) | 1.79414584 |
| 161 | Acute encephalopathy (HP:0006846) | 1.79362650 |
| 162 | Impaired social interactions (HP:0000735) | 1.78605460 |
| 163 | Abnormal social behavior (HP:0012433) | 1.78605460 |
| 164 | Diminished motivation (HP:0000745) | 1.78484069 |
| 165 | Specific learning disability (HP:0001328) | 1.78384299 |
| 166 | Postural instability (HP:0002172) | 1.78083431 |
| 167 | Aplasia/Hypoplasia of the phalanges of the thumb (HP:0009658) | 1.77139104 |
| 168 | Parakeratosis (HP:0001036) | 1.77016595 |
| 169 | Clumsiness (HP:0002312) | 1.76553351 |
| 170 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 1.74990640 |
| 171 | Short 1st metacarpal (HP:0010034) | 1.74990640 |
| 172 | Spondylolisthesis (HP:0003302) | 1.74813795 |
| 173 | Anomalous pulmonary venous return (HP:0010772) | 1.73227680 |
| 174 | Humeroradial synostosis (HP:0003041) | 1.72098879 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DYRK3 | 3.72420989 |
| 2 | NTRK1 | 3.60435042 |
| 3 | NTRK3 | 3.43402067 |
| 4 | ADRBK2 | 3.33076034 |
| 5 | KSR2 | 3.32704269 |
| 6 | EPHA4 | 3.30621064 |
| 7 | PKN2 | 3.04454871 |
| 8 | MAP3K12 | 3.02162398 |
| 9 | MAP3K9 | 2.94670711 |
| 10 | RPS6KA4 | 2.68756525 |
| 11 | ARAF | 2.66802096 |
| 12 | MST4 | 2.55117514 |
| 13 | MAP3K2 | 2.53756084 |
| 14 | GRK5 | 2.46520721 |
| 15 | RIPK4 | 2.44654114 |
| 16 | MINK1 | 2.38889832 |
| 17 | FLT3 | 2.27547762 |
| 18 | CASK | 2.16079166 |
| 19 | DAPK2 | 2.08076505 |
| 20 | LIMK1 | 1.78846366 |
| 21 | EPHB2 | 1.77621711 |
| 22 | MARK1 | 1.59000097 |
| 23 | CDK5 | 1.48426952 |
| 24 | MAP2K4 | 1.45545148 |
| 25 | DAPK1 | 1.38619602 |
| 26 | TNIK | 1.36073338 |
| 27 | MAPK13 | 1.32621010 |
| 28 | ERBB3 | 1.30741891 |
| 29 | FER | 1.26460520 |
| 30 | STK38 | 1.25466565 |
| 31 | LMTK2 | 1.24636562 |
| 32 | MAP3K1 | 1.23222554 |
| 33 | MAP3K4 | 1.22881426 |
| 34 | NTRK2 | 1.22328504 |
| 35 | FES | 1.21299969 |
| 36 | UHMK1 | 1.21149294 |
| 37 | MAP2K7 | 1.19443192 |
| 38 | SIK3 | 1.18366378 |
| 39 | FRK | 1.17152841 |
| 40 | MAP3K6 | 1.13515170 |
| 41 | CDK19 | 1.12619770 |
| 42 | RET | 1.10739942 |
| 43 | TAOK1 | 1.08995733 |
| 44 | DYRK2 | 1.06100020 |
| 45 | LATS1 | 1.04973065 |
| 46 | CAMKK1 | 1.04063201 |
| 47 | CDK14 | 1.00842233 |
| 48 | TNK2 | 1.00481509 |
| 49 | NME1 | 0.99420516 |
| 50 | MAP3K13 | 0.93510233 |
| 51 | PAK6 | 0.92568104 |
| 52 | CAMK4 | 0.91236024 |
| 53 | KSR1 | 0.89989538 |
| 54 | DYRK1A | 0.89343524 |
| 55 | CDK18 | 0.88877027 |
| 56 | DAPK3 | 0.88563774 |
| 57 | MAP2K1 | 0.87665894 |
| 58 | STK16 | 0.87089915 |
| 59 | PRKCE | 0.85244324 |
| 60 | ROCK1 | 0.85136108 |
| 61 | PRKCG | 0.84040462 |
| 62 | ROCK2 | 0.83382728 |
| 63 | SIK2 | 0.82812665 |
| 64 | CDK15 | 0.82593515 |
| 65 | PRKD3 | 0.82236443 |
| 66 | PHKG2 | 0.81987020 |
| 67 | PHKG1 | 0.81987020 |
| 68 | TESK1 | 0.81638108 |
| 69 | WNK3 | 0.81068819 |
| 70 | PRPF4B | 0.80983366 |
| 71 | MAPKAPK3 | 0.80651342 |
| 72 | MATK | 0.79000785 |
| 73 | BCKDK | 0.77763422 |
| 74 | PINK1 | 0.76089707 |
| 75 | ZAK | 0.74493791 |
| 76 | MARK2 | 0.74435064 |
| 77 | CAMK2B | 0.74423866 |
| 78 | PRKCZ | 0.73452915 |
| 79 | CAMK2A | 0.72029441 |
| 80 | MYLK | 0.71341505 |
| 81 | CDK11A | 0.70747929 |
| 82 | SGK494 | 0.70033668 |
| 83 | SGK223 | 0.70033668 |
| 84 | BCR | 0.68954774 |
| 85 | OXSR1 | 0.68531229 |
| 86 | STK24 | 0.68135239 |
| 87 | TLK1 | 0.67907757 |
| 88 | PLK2 | 0.66857488 |
| 89 | MAP3K5 | 0.66747332 |
| 90 | CAMKK2 | 0.65924111 |
| 91 | CAMK2D | 0.63461031 |
| 92 | KDR | 0.63054844 |
| 93 | PRKCH | 0.62857828 |
| 94 | AKT3 | 0.61702897 |
| 95 | ADRBK1 | 0.61303000 |
| 96 | LATS2 | 0.61211142 |
| 97 | PDPK1 | 0.60154403 |
| 98 | MKNK2 | 0.59895504 |
| 99 | STK11 | 0.59401699 |
| 100 | BRAF | 0.59399308 |
| 101 | DYRK1B | 0.58128831 |
| 102 | PRKG1 | 0.56373104 |
| 103 | CSNK1G2 | 0.56130732 |
| 104 | PTK2B | 0.55446792 |
| 105 | PNCK | 0.54155051 |
| 106 | RAF1 | 0.54032478 |
| 107 | SGK3 | 0.53903303 |
| 108 | MAPKAPK5 | 0.53792701 |
| 109 | PRKACB | 0.52467088 |
| 110 | TIE1 | 0.52463124 |
| 111 | SCYL2 | 0.52293820 |
| 112 | RPS6KA2 | 0.52205351 |
| 113 | PDK1 | 0.51140355 |
| 114 | TRIM28 | 0.50982521 |
| 115 | BMPR2 | 0.49905540 |
| 116 | TGFBR1 | 0.48578754 |
| 117 | PDK3 | 0.48204401 |
| 118 | PDK4 | 0.48204401 |
| 119 | MAP2K3 | 0.47214475 |
| 120 | PRKACA | 0.46500427 |
| 121 | MAP3K7 | 0.45611300 |
| 122 | LRRK2 | 0.44898586 |
| 123 | STK38L | 0.44245482 |
| 124 | MAPK4 | 0.44166984 |
| 125 | CAMK2G | 0.42098237 |
| 126 | FYN | 0.41838189 |
| 127 | SGK2 | 0.41661957 |
| 128 | CSNK1G3 | 0.41388657 |
| 129 | GSK3A | 0.40652722 |
| 130 | NEK1 | 0.39370144 |
| 131 | FGR | 0.37780279 |
| 132 | RPS6KA5 | 0.37705760 |
| 133 | STK39 | 0.37311384 |
| 134 | MAP2K6 | 0.36975965 |
| 135 | BMPR1B | 0.36234075 |
| 136 | PAK3 | 0.36112990 |
| 137 | RIPK1 | 0.35916697 |
| 138 | PKN1 | 0.35484035 |
| 139 | SRPK1 | 0.34589257 |
| 140 | CDK8 | 0.33330236 |
| 141 | TYRO3 | 0.33212111 |
| 142 | SRC | 0.33201815 |
| 143 | MARK3 | 0.31884845 |
| 144 | PRKD2 | 0.31350352 |
| 145 | GRK1 | 0.30372143 |
| 146 | CSNK1A1L | 0.30318347 |
| 147 | STK3 | 0.28252629 |
| 148 | INSRR | 0.27761867 |
| 149 | PRKD1 | 0.27017565 |
| 150 | CSNK1G1 | 0.25491674 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 3.53183183 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.10074554 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.74315707 |
| 4 | Nicotine addiction_Homo sapiens_hsa05033 | 2.69287240 |
| 5 | GABAergic synapse_Homo sapiens_hsa04727 | 2.53574146 |
| 6 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.46384896 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 2.36286434 |
| 8 | Protein export_Homo sapiens_hsa03060 | 2.32533420 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.28501146 |
| 10 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.26161983 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 2.21129904 |
| 12 | Parkinsons disease_Homo sapiens_hsa05012 | 2.19324457 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.16483715 |
| 14 | Renin secretion_Homo sapiens_hsa04924 | 2.15914538 |
| 15 | Circadian entrainment_Homo sapiens_hsa04713 | 2.12481798 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 2.03660017 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.97371061 |
| 18 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.90949014 |
| 19 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.90401417 |
| 20 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.85491837 |
| 21 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.78217414 |
| 22 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.76997788 |
| 23 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.76982682 |
| 24 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.76600955 |
| 25 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.75331578 |
| 26 | Long-term depression_Homo sapiens_hsa04730 | 1.74785950 |
| 27 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.73375828 |
| 28 | Alzheimers disease_Homo sapiens_hsa05010 | 1.72070626 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.71362559 |
| 30 | Cocaine addiction_Homo sapiens_hsa05030 | 1.69730478 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.64402413 |
| 32 | Salivary secretion_Homo sapiens_hsa04970 | 1.59519519 |
| 33 | Taste transduction_Homo sapiens_hsa04742 | 1.52195064 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.49302244 |
| 35 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.39632597 |
| 36 | Gap junction_Homo sapiens_hsa04540 | 1.38085680 |
| 37 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.37570611 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.36592766 |
| 39 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.26515199 |
| 40 | Huntingtons disease_Homo sapiens_hsa05016 | 1.25794645 |
| 41 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.24539878 |
| 42 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.23774117 |
| 43 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.13625852 |
| 44 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.13348801 |
| 45 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.12791479 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.10339996 |
| 47 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.08922680 |
| 48 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.06871881 |
| 49 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.02673902 |
| 50 | Glioma_Homo sapiens_hsa05214 | 1.01050399 |
| 51 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.97813959 |
| 52 | Melanogenesis_Homo sapiens_hsa04916 | 0.95662512 |
| 53 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.94813968 |
| 54 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.93333180 |
| 55 | Phototransduction_Homo sapiens_hsa04744 | 0.93250711 |
| 56 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.92950125 |
| 57 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.90242692 |
| 58 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.88609426 |
| 59 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.87364916 |
| 60 | Thyroid cancer_Homo sapiens_hsa05216 | 0.86579547 |
| 61 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.83478399 |
| 62 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.81445087 |
| 63 | Axon guidance_Homo sapiens_hsa04360 | 0.81146368 |
| 64 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.74977909 |
| 65 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.73969450 |
| 66 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.72971866 |
| 67 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70457133 |
| 68 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.70223274 |
| 69 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68940221 |
| 70 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.65374978 |
| 71 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.65348594 |
| 72 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.65151962 |
| 73 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.64676563 |
| 74 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.64587529 |
| 75 | Prion diseases_Homo sapiens_hsa05020 | 0.63488795 |
| 76 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.63224038 |
| 77 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.63177409 |
| 78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.61542795 |
| 79 | Bile secretion_Homo sapiens_hsa04976 | 0.61272388 |
| 80 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.60981592 |
| 81 | Melanoma_Homo sapiens_hsa05218 | 0.60944069 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.60681192 |
| 83 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59085821 |
| 84 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.57323504 |
| 85 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.57084343 |
| 86 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.57067081 |
| 87 | Alcoholism_Homo sapiens_hsa05034 | 0.56071257 |
| 88 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.56020276 |
| 89 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.53786371 |
| 90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.53356287 |
| 91 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52330463 |
| 92 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.52096745 |
| 93 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.51665649 |
| 94 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.51601568 |
| 95 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51236226 |
| 96 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.51089617 |
| 97 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.51032863 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.48837108 |
| 99 | Endocytosis_Homo sapiens_hsa04144 | 0.48319708 |
| 100 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47161616 |
| 101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.46669144 |
| 102 | Circadian rhythm_Homo sapiens_hsa04710 | 0.44952844 |
| 103 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43211301 |
| 104 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.41935314 |
| 105 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.41526201 |
| 106 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.41425129 |
| 107 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.41401055 |
| 108 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.40351407 |
| 109 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.39782519 |
| 110 | Bladder cancer_Homo sapiens_hsa05219 | 0.39755257 |
| 111 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.38991388 |
| 112 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.38633908 |
| 113 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.38428881 |
| 114 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.38401481 |
| 115 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.37940696 |
| 116 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.37779684 |
| 117 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.36545306 |
| 118 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.35105855 |
| 119 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.32890829 |
| 120 | Phagosome_Homo sapiens_hsa04145 | 0.32484095 |
| 121 | Retinol metabolism_Homo sapiens_hsa00830 | 0.32221136 |
| 122 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.29738512 |
| 123 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.29071917 |
| 124 | Platelet activation_Homo sapiens_hsa04611 | 0.28034470 |
| 125 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.27113775 |
| 126 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.26754649 |
| 127 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.25719563 |
| 128 | RNA degradation_Homo sapiens_hsa03018 | 0.23703273 |
| 129 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.23267571 |
| 130 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.22968397 |
| 131 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.22503017 |
| 132 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.22254300 |
| 133 | ABC transporters_Homo sapiens_hsa02010 | 0.20958320 |
| 134 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.20335987 |
| 135 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.19237662 |
| 136 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.18916764 |
| 137 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.17842334 |

